REG - AIM Beximco Pharma. - Suspension - Beximco Pharmaceuticals Limited

Beximco PharmaceuticalsAnnouncement

11/11/2024 07:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241111:nRSK6851La&default-theme=true

RNS Number : 6851L  AIM  11 November 2024

NOTICE

 

11/11/2024 7:30am

 

TEMPORARY SUSPENSION OF TRADING ON AIM

 

BEXIMCO PHARMACEUTICALS LIMITED

 

At the request of the Company, trading on AIM for the under-mentioned
securities was temporarily suspended from 11/11/2024 7:30am, pending an
announcement.

 

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH),
FULLY PAID

(B0DM5S5) (US0885792061)

 

If you have any queries relating to the above, please contact the Company's
nominated adviser on +44 (0) 20 3368 3551.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  EXCZZMMMNMGGDZG